Intermediateapplied biology

Cancer Biology Basics: When Cell Division Goes Wrong

Learning objectives

  • Describe how the cell cycle is regulated and what checkpoints do.
  • Distinguish proto-oncogenes from tumor-suppressor genes such as p53 and RB.
  • List and explain the hallmarks of cancer.
  • Describe the steps of metastasis.
  • Explain how surgery, chemotherapy, radiation, targeted therapy, and immunotherapy exploit cancer biology.

The Cell Cycle and Its Checkpoints

Healthy cell division is tightly choreographed. The cell cycle moves through growth phases (G1, G2), DNA synthesis (S), and mitosis (M), driven by cyclins and cyclin-dependent kinases that act like molecular switches. Checkpoints inspect progress: the G1 checkpoint asks whether DNA is undamaged and conditions are right, the G2 checkpoint verifies DNA was copied correctly, and the spindle checkpoint confirms chromosomes are properly attached before they are pulled apart. If damage is found, the cell pauses for repair or, if repair fails, triggers apoptosis, programmed cell death. Cancer begins when these controls fail and a cell divides despite damage or without permission, passing errors to its daughters.

Genes That Guard Against Cancer

Two gene classes police cell division. Proto-oncogenes normally promote controlled growth, for example by relaying growth signals; when mutated into oncogenes, they become stuck in the on position, driving relentless division. Tumor-suppressor genes do the opposite: they brake the cycle or trigger death of damaged cells. The most famous, p53, is called the guardian of the genome because it halts division when DNA is damaged; it is mutated in roughly half of all human cancers. RB governs the G1 checkpoint. Knudson's two-hit hypothesis explains why both copies of a tumor suppressor usually must be lost: one inherited faulty copy plus one acquired mutation, which is why some cancer predispositions run in families while most cancers arise from mutations accumulated over a lifetime.

The Hallmarks of Cancer

In 2000, Hanahan and Weinberg distilled cancer's complexity into hallmarks, capabilities that developing tumors acquire. Cancer cells sustain proliferative signaling and evade growth suppressors, resist cell death, and achieve replicative immortality, often by reactivating telomerase, the enzyme that rebuilds chromosome ends. They induce angiogenesis, coaxing blood vessels to feed the tumor, and activate invasion and metastasis programs. They reprogram energy metabolism toward glycolysis even with oxygen present, and they evade immune destruction. Underlying all of this is genome instability, which accelerates the mutation rate. Not every tumor shows every hallmark, but the framework explains why cancer is so adaptable: it is evolution, mutation plus selection, happening inside a single body.

Cancer as evolution

A tumor is a population of cells undergoing mutation and natural selection. Therapies impose selection pressure, which is why resistance to cancer drugs can evolve much like antibiotic resistance.

Benign Versus Malignant Tumors

A tumor is simply a mass of abnormally dividing cells, but not all tumors are cancer. Benign tumors grow locally, remain encapsulated, and do not invade neighboring tissue or spread; many never threaten health, though some can cause problems by pressing on organs. Malignant tumors are cancers: they invade surrounding tissue and can metastasize. Metastasis is a multi-step ordeal: cells detach, invade nearby tissue, enter blood or lymph vessels, survive circulation, exit at a distant site, and colonize a new organ. Each step kills the vast majority of traveling cells, which is why metastasis is inefficient yet so dangerous when it succeeds. Most cancer deaths come from metastases, not the original tumor, because secondary growths disrupt vital organs.

How Treatments Target Cancer Biology

Each major treatment exploits a biological vulnerability. Surgery physically removes localized tumors. Chemotherapy poisons dividing cells, which hits cancer hard but also damages fast-dividing healthy tissues like bone marrow and gut lining, causing classic side effects. Radiation breaks DNA in a targeted region, overwhelming cancer cells' already shaky repair. Targeted therapies block specific oncogenic proteins, such as drugs inhibiting the BCR-ABL fusion protein in chronic myeloid leukemia. Immunotherapies remove the brakes cancer puts on immunity: checkpoint inhibitors free T cells to attack tumors, and CAR-T therapy engineers a patient's own T cells to recognize cancer. Because tumors evolve, combination treatments that attack multiple hallmarks at once are often more durable than any single approach.

Educational content only

This article explains cancer biology. It is not medical advice; diagnosis and treatment decisions belong to oncology professionals.

Key points

  • Checkpoints and apoptosis normally prevent damaged cells from dividing; cancer arises when these controls fail.
  • Oncogenes drive division; tumor suppressors like p53 and RB restrain it.
  • The hallmarks of cancer describe the capabilities tumors evolve, including immortality, angiogenesis, and metastasis.
  • Benign tumors stay local; malignant tumors invade and can metastasize through blood or lymph.
  • Treatments exploit cancer biology: surgery, chemotherapy, radiation, targeted drugs, and immunotherapy.

Common misconceptions

✗ Myth: Cancer is a single disease.

✓ Truth: Cancer is hundreds of diseases defined by tissue of origin and mutation profile. A lung tumor driven by an EGFR mutation behaves differently from one driven by KRAS, which is why treatment is increasingly matched to the tumor's genetics.

✗ Myth: Sugar feeds cancer, so cutting sugar starves tumors.

✓ Truth: All cells use glucose, and the body tightly regulates blood sugar; you cannot selectively starve a tumor by diet. The observation behind the myth is real, cancer cells consume extra glucose, but it does not translate into a dietary cure.

✗ Myth: Every lump is cancer.

✓ Truth: Most lumps are benign cysts, lipomas, or inflammation. Only biopsy and pathology can determine whether a mass is malignant, which is why new or changing lumps merit medical evaluation rather than assumption.

Frequently asked questions

Is cancer contagious?

No. Cancer cannot spread from person to person like an infection. A few viruses, such as HPV and hepatitis B, raise cancer risk by damaging DNA or causing chronic inflammation, which is why vaccines against them also prevent cancers, but the tumor itself is not transmissible.

What causes the mutations that lead to cancer?

Mutations come from DNA replication errors, which happen at a low rate every division, plus damage from tobacco smoke, ultraviolet light, certain chemicals, and some viruses. Most mutations are harmless or repaired; cancer requires a rare combination hitting growth-control genes in one cell lineage.

Can the immune system fight cancer on its own?

It tries. Immune surveillance destroys many abnormal cells before they become tumors, and people with weakened immunity have higher cancer rates. But successful cancers evolve ways to hide from or suppress immune attack, which is exactly what immunotherapy aims to reverse.

Why does cancer become resistant to treatment?

Because tumors are evolving cell populations. Therapy kills sensitive cells, leaving resistant mutants to regrow, the same selection logic as antibiotic resistance. This is why oncologists use combinations and monitor for relapse.